Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 1652

1.

Antithrombotic therapy for chronic coronary syndrome and atrial fibrillation: less might be more.

Wernly B, Bhatt DL, Polzin A, Jung C.

J Thromb Thrombolysis. 2019 Dec 3. doi: 10.1007/s11239-019-02007-4. [Epub ahead of print]

PMID:
31797240
2.

Minding the Gaps in Post-Myocardial Infarction Mortality Between Sweden and the UK.

Peterson BE, Bhatt DL.

Cardiovasc Res. 2019 Nov 28. pii: cvz281. doi: 10.1093/cvr/cvz281. [Epub ahead of print] No abstract available.

PMID:
31782765
3.

Global perspective on carotid intima-media thickness and plaque: should the current measurement guidelines be revisited?

Saba L, Jamthikar A, Gupta D, Khanna NN, Viskovic K, Suri HS, Gupta A, Mavrogeni S, Turk M, Laird JR, Pareek G, Miner M, Sfikakis P, Protogerou A, Kitas GD, Viswanathan V, Nicolaides A, Bhatt D, Suri JS.

Int Angiol. 2019 Nov 25. doi: 10.23736/S0392-9590.19.04267-6. [Epub ahead of print]

PMID:
31782286
4.

Recurrent spontaneous coronary artery dissection in the United States.

Krittanawong C, Kumar A, Virk HUH, Wang Z, Johnson KW, Yue B, Bhatt DL.

Int J Cardiol. 2019 Nov 13. pii: S0167-5273(19)34019-7. doi: 10.1016/j.ijcard.2019.10.052. [Epub ahead of print]

PMID:
31757645
5.
6.

Association of Premature Natural and Surgical Menopause With Incident Cardiovascular Disease.

Honigberg MC, Zekavat SM, Aragam K, Finneran P, Klarin D, Bhatt DL, Januzzi JL Jr, Scott NS, Natarajan P.

JAMA. 2019 Nov 18. doi: 10.1001/jama.2019.19191. [Epub ahead of print]

PMID:
31738818
7.

A low-cost machine learning-based cardiovascular/stroke risk assessment system: integration of conventional factors with image phenotypes.

Jamthikar A, Gupta D, Khanna NN, Saba L, Araki T, Viskovic K, Suri HS, Gupta A, Mavrogeni S, Turk M, Laird JR, Pareek G, Miner M, Sfikakis PP, Protogerou A, Kitas GD, Viswanathan V, Nicolaides A, Bhatt DL, Suri JS.

Cardiovasc Diagn Ther. 2019 Oct;9(5):420-430. doi: 10.21037/cdt.2019.09.03.

8.

Effect of alirocumab on cardiovascular outcomes after acute coronary syndromes according to age: an ODYSSEY OUTCOMES trial analysis.

Sinnaeve PR, Schwartz GG, Wojdyla DM, Alings M, Bhatt DL, Bittner VA, Chiang CE, Correa Flores RM, Diaz R, Dorobantu M, Goodman SG, Jukema JW, Kim YU, Pordy R, Roe MT, Sy RG, Szarek M, White HD, Zeiher AM, Steg PG; ODYSSEY OUTCOMES Investigators.

Eur Heart J. 2019 Nov 16. pii: ehz809. doi: 10.1093/eurheartj/ehz809. [Epub ahead of print]

PMID:
31732742
9.

Long-Term Cardiovascular Risk in Women With Hypertension During Pregnancy.

Honigberg MC, Zekavat SM, Aragam K, Klarin D, Bhatt DL, Scott NS, Peloso GM, Natarajan P.

J Am Coll Cardiol. 2019 Dec 3;74(22):2743-2754. doi: 10.1016/j.jacc.2019.09.052. Epub 2019 Nov 11.

PMID:
31727424
10.

Getting to an ImprOved Understanding of Low-Density Lipoprotein-Cholesterol and Dyslipidemia Management (GOULD): Methods and baseline data of a registry of high cardiovascular risk patients in the United States.

Cannon CP, de Lemos JA, Rosenson RS, Ballantyne CM, Liu Y, Yazdi D, Elliott-Davey M, Mues KE, Bhatt DL, Kosiborod MN; GOULD Investigators.

Am Heart J. 2019 Oct 31;219:70-77. doi: 10.1016/j.ahj.2019.10.014. [Epub ahead of print]

11.

Risk Factors and Outcomes of Very Young Adults Who Experience Myocardial Infarction: The Partners YOUNG-MI Registry.

Yang J, Biery D, Singh A, Divakaran S, DeFilippis EM, Wu WY, Klein J, Hainer J, Ramsis M, Natarajan P, Januzzi JL, Nasir K, Bhatt DL, Di Carli MF, Blankstein R.

Am J Med. 2019 Nov 9. pii: S0002-9343(19)30962-3. doi: 10.1016/j.amjmed.2019.10.020. [Epub ahead of print]

PMID:
31715169
12.

REDUCE-IT USA: Results from the 3,146 Patients Randomized in the United States.

Bhatt DL, Miller M, Brinton EA, Jacobson TA, Steg PG, Ketchum SB, Doyle RT, Juliano RA, Jiao L, Granowitz C, Tardif JC, Olshansky B, Chung MK, Gibson CM, Giugliano RP, Budoff MJ, Ballantyne CM; REDUCE-IT Investigators.

Circulation. 2019 Nov 11. doi: 10.1161/CIRCULATIONAHA.119.044440. [Epub ahead of print]

PMID:
31707829
13.

Alirocumab Reduces Total Hospitalizations and Increases Days Alive and Out of Hospital in the ODYSSEY OUTCOMES Trial.

Szarek M, Steg PG, DiCenso D, Bhatt DL, Bittner VA, Budaj A, Diaz R, Goodman SG, Gotcheva N, Jukema JW, Pordy R, Roe MT, Sourdille T, White HD, Xavier D, Zeiher AM, Schwartz GG.

Circ Cardiovasc Qual Outcomes. 2019 Nov;12(11):e005858. doi: 10.1161/CIRCOUTCOMES.119.005858. Epub 2019 Nov 11.

PMID:
31707826
14.

Effect of Alirocumab on Stroke in ODYSSEY OUTCOMES.

Jukema JW, Zijlstra LE, Bhatt DL, Bittner VA, Diaz R, Drexel H, Goodman SG, Kim YU, Pordy R, Reiner Z, Roe MT, Tse HF, Valdovinos PCM, White HD, Zeiher AM, Szarek M, Schwartz GG, Steg PG; ODYSSEY OUTCOMES Investigators.

Circulation. 2019 Nov 11. doi: 10.1161/CIRCULATIONAHA.119.043826. [Epub ahead of print] No abstract available.

PMID:
31707788
15.

Dabigatran Dual Therapy Versus Warfarin Triple Therapy in Atrial Fibrillation Post-PCI: Time in Therapeutic Range.

Lip GYH, Bhatt DL, Hohnloser SH, Kimura T, Miede C, Nordaby M, Oldgren J, Steg PG, Ten Berg JM, Cannon CP.

J Am Coll Cardiol. 2019 Nov 12;74(19):2431-2433. doi: 10.1016/j.jacc.2019.09.009. No abstract available.

PMID:
31699285
16.

Antiarrhythmic Drugs or Catheter Ablation in the Management of Ventricular Tachyarrhythmias in Patients With Implantable Cardioverter-Defibrillators: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.

Kheiri B, Barbarawi M, Zayed Y, Hicks M, Osman M, Rashdan L, Kyi HH, Bachuwa G, Hassan M, Stecker EC, Nazer B, Bhatt DL.

Circ Arrhythm Electrophysiol. 2019 Nov;12(11):e007600. doi: 10.1161/CIRCEP.119.007600. Epub 2019 Nov 8.

PMID:
31698933
17.

The DAPA-HF Trial: A Momentous Victory in the War against Heart Failure.

Bhatt DL, Verma S, Braunwald E.

Cell Metab. 2019 Nov 5;30(5):847-849. doi: 10.1016/j.cmet.2019.10.008.

PMID:
31693879
18.

Targeting kidneys by superparamagnetic allopurinol loaded chitosan coated nanoparticles for the treatment of hyperuricemic nephrolithiasis.

Kandav G, Bhatt DC, Jindal DK.

Daru. 2019 Nov 5. doi: 10.1007/s40199-019-00300-4. [Epub ahead of print]

19.

Detection of self-generated nanowaves on the interface of an evaporating sessile water droplet.

Bhatt D, Vaippully R, Kharbanda B, Dev Ranjan A, R S, Dharod V, Satapathy D, Roy B.

Opt Express. 2019 Oct 28;27(22):31900-31912. doi: 10.1364/OE.27.031900.

PMID:
31684413
20.

Performance of Current Risk Models in Predicting Short-Term Mortality After Transcatheter Aortic Valve Replacement: A Systematic Review and Meta-Analysis.

Siddiqi TJ, Usman MS, Khan MS, Khan MAA, Riaz H, Khan SU, Murad MH, Kavinsky CJ, Doukky R, Kalra A, Desai MY, Bhatt DL.

EuroIntervention. 2019 Oct 29. pii: EIJ-D-19-00636. doi: 10.4244/EIJ-D-19-00636. [Epub ahead of print]

21.

Systolic and Diastolic Blood Pressure and Cardiovascular Outcomes. Reply.

Flint AC, Conell C, Bhatt DL.

N Engl J Med. 2019 Oct 24;381(17):1692-1693. doi: 10.1056/NEJMc1911059. No abstract available.

PMID:
31644861
22.

Risk factors and clinical outcomes in chronic coronary and peripheral artery disease: An analysis of the randomized, double-blind COMPASS trial.

Vanassche T, Verhamme P, Anand SS, Shestakovska O, Fox KA, Bhatt DL, Avezum A, Alings M, Aboyans V, Maggioni AP, Widimsky P, Berkowitz SD, Yusuf S, Connolly SJ, Eikelboom JW, Bosch J.

Eur J Prev Cardiol. 2019 Oct 15:2047487319882154. doi: 10.1177/2047487319882154. [Epub ahead of print]

PMID:
31615291
23.

Antithrombotic treatment after coronary artery bypass graft surgery: systematic review and network meta-analysis.

Solo K, Lavi S, Kabali C, Levine GN, Kulik A, John-Baptiste AA, Fremes SE, Martin J, Eikelboom JW, Ruel M, Huitema AA, Choudhury T, Bhatt DL, Tzemos N, Mamas MA, Bagur R.

BMJ. 2019 Oct 10;367:l5476. doi: 10.1136/bmj.l5476.

24.

Preventive Cardiology as a Subspecialty of Cardiovascular Medicine: JACC Council Perspectives.

Shapiro MD, Maron DJ, Morris PB, Kosiborod M, Sandesara PB, Virani SS, Khera A, Ballantyne CM, Baum SJ, Sperling LS, Bhatt DL, Fazio S.

J Am Coll Cardiol. 2019 Oct 15;74(15):1926-1942. doi: 10.1016/j.jacc.2019.08.1016. Review.

PMID:
31601373
25.

Design and rationale of the North Indian ST-Segment Elevation Myocardial Infarction Registry: A prospective cohort study.

Arora S, Qamar A, Gupta P, Vaduganathan M, Chauhan I, Tripathi AK, Sharma VY, Bansal A, Fatima A, Jain G, Batra V, Tyagi S, Khandelwal L, Kaul P, Rao SV, Girish MP, Bhatt DL, Gupta MD.

Clin Cardiol. 2019 Oct 8. doi: 10.1002/clc.23278. [Epub ahead of print]

26.

Reply: Ischemic Event Reduction and Triglycerides.

Bhatt DL, Steg PG, Miller M, Juliano RA, Ballantyne CM.

J Am Coll Cardiol. 2019 Oct 8;74(14):1849-1850. doi: 10.1016/j.jacc.2019.08.007. No abstract available.

PMID:
31582151
27.

Cardiovascular Toxicities of Immune Checkpoint Inhibitors: JACC Review Topic of the Week.

Ball S, Ghosh RK, Wongsaengsak S, Bandyopadhyay D, Ghosh GC, Aronow WS, Fonarow GC, Lenihan DJ, Bhatt DL.

J Am Coll Cardiol. 2019 Oct 1;74(13):1714-1727. doi: 10.1016/j.jacc.2019.07.079. Review. Erratum in: J Am Coll Cardiol. 2019 Nov 26;74(21):2711-2712.

PMID:
31558256
28.

Benefit and Risks of Aspirin in Addition to Ticagrelor in Acute Coronary Syndromes: A Post Hoc Analysis of the Randomized GLOBAL LEADERS Trial.

Tomaniak M, Chichareon P, Onuma Y, Deliargyris EN, Takahashi K, Kogame N, Modolo R, Chang CC, Rademaker-Havinga T, Storey RF, Dangas GD, Bhatt DL, Angiolillo DJ, Hamm C, Valgimigli M, Windecker S, Steg PG, Vranckx P, Serruys PW; GLOBAL LEADERS Trial Investigators.

JAMA Cardiol. 2019 Sep 26. doi: 10.1001/jamacardio.2019.3355. [Epub ahead of print]

PMID:
31557763
29.

Aortic Valve Replacement in Bioprosthetic Failure:Insights from The Society of Thoracic Surgeons National Database.

Kalra A, Raza S, Hussain M, Shorbaji K, Delozier S, Deo SV, Khera S, Kleiman NS, Reardon MJ, Kolte D, Gupta T, Mustafa R, Bhatt DL, Sabik JF 3rd.

Ann Thorac Surg. 2019 Sep 23. pii: S0003-4975(19)31407-9. doi: 10.1016/j.athoracsur.2019.08.023. [Epub ahead of print]

PMID:
31557477
30.

Diabetes Is Associated With Worse Long-term Outcomes in Young Adults After Myocardial Infarction: The Partners YOUNG-MI Registry.

Divakaran S, Singh A, Biery D, Yang J, DeFilippis EM, Collins BL, Ramsis M, Qamar A, Hainer J, Klein J, Cannon CP, Polk DM, Plutzky J, Nasir K, Januzzi JL, Di Carli MF, Bhatt DL, Blankstein R.

Diabetes Care. 2019 Sep 23. pii: dc190998. doi: 10.2337/dc19-0998. [Epub ahead of print]

PMID:
31548242
31.

Relationship Between Troponin on Presentation and In-Hospital Mortality in Patients With ST-Segment-Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention.

Wanamaker BL, Seth MM, Sukul D, Dixon SR, Bhatt DL, Madder RD, Rumsfeld JS, Gurm HS.

J Am Heart Assoc. 2019 Oct;8(19):e013551. doi: 10.1161/JAHA.119.013551. Epub 2019 Sep 24.

32.

THEMIS and THEMIS-PCI.

Bhatt DL, Steg PG.

Eur Heart J. 2019 Nov 1;40(41):3378-3381. doi: 10.1093/eurheartj/ehz707. No abstract available.

PMID:
31545357
33.

Major Bleeding in Patients With Coronary or Peripheral Artery Disease Treated With Rivaroxaban Plus Aspirin.

Eikelboom JW, Bosch JJ, Connolly SJ, Shestakovska O, Dagenais GR, Hart RG, Leong DP, O'Donnell M, Fox KAA, Bhatt DL, Cairns JA, Tasto C, Berkowitz SD, Cook Bruns N, Muehlhofer E, Diaz R, Maggioni AP, Yusuf S.

J Am Coll Cardiol. 2019 Sep 24;74(12):1519-1528. doi: 10.1016/j.jacc.2019.07.065.

34.

Association of Acute Venous Thromboembolism With In-Hospital Outcomes of Coronary Artery Bypass Graft Surgery.

Panhwar MS, Ginwalla M, Kalra A, Gupta T, Kolte D, Khera S, Bhatt DL, Sabik JF 3rd.

J Am Heart Assoc. 2019 Oct;8(19):e013246. doi: 10.1161/JAHA.119.013246. Epub 2019 Sep 19.

35.

Intensive blood pressure lowering in different age categories: insights from the Systolic Blood Pressure Intervention Trial.

Byrne C, Pareek M, Vaduganathan M, Biering-Sørensen T, Qamar A, Pandey A, Olesen TB, Olsen MH, Bhatt DL.

Eur Heart J Cardiovasc Pharmacother. 2019 Sep 14. pii: pvz050. doi: 10.1093/ehjcvp/pvz050. [Epub ahead of print]

PMID:
31529024
36.

Cardiometabolic risk reduction after metabolic surgery.

Pareek M, Bhatt DL.

Curr Opin Cardiol. 2019 Nov;34(6):663-672. doi: 10.1097/HCO.0000000000000683.

PMID:
31524661
37.
38.

Bleeding and New Cancer Diagnosis in Patients With Atherosclerosis.

Eikelboom JW, Connolly SJ, Bosch J, Shestakovska O, Aboyans V, Alings M, Anand SS, Avezum A, Berkowitz SD, Bhatt DL, Cook-Bruns N, Felix C, Fox KAA, Hart RG, Maggioni AP, Moayyedi P, O'Donnell M, Rydén L, Verhamme P, Widimsky P, Zhu J, Yusuf S.

Circulation. 2019 Oct 29;140(18):1451-1459. doi: 10.1161/CIRCULATIONAHA.119.041949. Epub 2019 Sep 12.

PMID:
31510769
39.

Leadership in Cardiovascular Medicine.

Shaikh AA, Bhatt DL, Kalra A.

Eur Heart J. 2019 May 7;40(18):1395-1397. doi: 10.1093/eurheartj/ehz257. No abstract available.

PMID:
31506693
40.

Performance of Dynamic Automated CT Annular Measurements Compared to Standard Manual Measurements for Transcatheter Aortic Valve Replacement Sizing.

Truong QA, Legasto AC, Deaño RC, Bachman DP, Bhatt D, Al'Aref SJ, Devereux RB, Wong SC, Salemi A, Szymonifka J.

Radiol Cardiothorac Imaging. 2019 Aug;1(3). pii: e180025. doi: 10.1148/ryct.2019180025. Epub 2019 Aug 29.

41.

Ticagrelor in patients with diabetes and stable coronary artery disease with a history of previous percutaneous coronary intervention (THEMIS-PCI): a phase 3, placebo-controlled, randomised trial.

Bhatt DL, Steg PG, Mehta SR, Leiter LA, Simon T, Fox K, Held C, Andersson M, Himmelmann A, Ridderstråle W, Chen J, Song Y, Diaz R, Goto S, James SK, Ray KK, Parkhomenko AN, Kosiborod MN, McGuire DK, Harrington RA; THEMIS Steering Committee and Investigators.

Lancet. 2019 Sep 28;394(10204):1169-1180. doi: 10.1016/S0140-6736(19)31887-2. Epub 2019 Sep 1.

42.

Transcatheter Aortic Valve Replacement in Low-Risk Patients.

Tang GHL, Verma S, Bhatt DL.

Circulation. 2019 Sep 9;140(10):801-803. doi: 10.1161/CIRCULATIONAHA.119.041111. Epub 2019 Sep 3. No abstract available.

PMID:
31479314
43.

SGLT2 Inhibition with Empagliflozin Increases Circulating Provascular Progenitor Cells in People with Type 2 Diabetes Mellitus.

Hess DA, Terenzi DC, Trac JZ, Quan A, Mason T, Al-Omran M, Bhatt DL, Dhingra N, Rotstein OD, Leiter LA, Zinman B, Sabongui S, Yan AT, Teoh H, Mazer CD, Connelly KA, Verma S.

Cell Metab. 2019 Oct 1;30(4):609-613. doi: 10.1016/j.cmet.2019.08.015. Epub 2019 Aug 30.

PMID:
31477497
44.

Ticagrelor in Patients with Stable Coronary Disease and Diabetes.

Steg PG, Bhatt DL, Simon T, Fox K, Mehta SR, Harrington RA, Held C, Andersson M, Himmelmann A, Ridderstråle W, Leonsson-Zachrisson M, Liu Y, Opolski G, Zateyshchikov D, Ge J, Nicolau JC, Corbalán R, Cornel JH, Widimský P, Leiter LA; THEMIS Steering Committee and Investigators.

N Engl J Med. 2019 Oct 3;381(14):1309-1320. doi: 10.1056/NEJMoa1908077. Epub 2019 Sep 1.

PMID:
31475798
45.

Association of Genetic Variants Related to Combined Exposure to Lower Low-Density Lipoproteins and Lower Systolic Blood Pressure With Lifetime Risk of Cardiovascular Disease.

Ference BA, Bhatt DL, Catapano AL, Packard CJ, Graham I, Kaptoge S, Ference TB, Guo Q, Laufs U, Ruff CT, Cupido A, Hovingh GK, Danesh J, Holmes MV, Smith GD, Ray KK, Nicholls SJ, Sabatine MS.

JAMA. 2019 Sep 2. doi: 10.1001/jama.2019.14120. [Epub ahead of print]

PMID:
31475726
46.

Risk Categorization Using New American College of Cardiology/American Heart Association Guidelines for Cholesterol Management and Its Relation to Alirocumab Treatment Following Acute Coronary Syndromes.

Roe MT, Li QH, Bhatt DL, Bittner VA, Diaz R, Goodman SG, Harrington RA, Jukema JW, Lopez-Jaramillo P, Lopes RD, Louie MJ, Moriarty PM, Szarek M, Vogel R, White HD, Zeiher AM, Baccara-Dinet MT, Steg PG, Schwartz GG.

Circulation. 2019 Nov 5;140(19):1578-1589. doi: 10.1161/CIRCULATIONAHA.119.042551. Epub 2019 Sep 2.

47.

Heart Failure Risk Stratification and Efficacy of Sodium-Glucose Cotransporter-2 Inhibitors in Patients With Type 2 Diabetes Mellitus.

Berg DD, Wiviott SD, Scirica BM, Gurmu Y, Mosenzon O, Murphy SA, Bhatt DL, Leiter LA, McGuire DK, Wilding JPH, Johanson P, Johansson PA, Langkilde AM, Raz I, Braunwald E, Sabatine MS.

Circulation. 2019 Nov 5;140(19):1569-1577. doi: 10.1161/CIRCULATIONAHA.119.042685. Epub 2019 Aug 31.

PMID:
31474116
48.

Fluorodeoxyglucose Uptake in Atheroma: Not So Simple.

Libby P, Bhatt DL, Di Carli M.

J Am Coll Cardiol. 2019 Sep 3;74(9):1233-1236. doi: 10.1016/j.jacc.2019.07.009. No abstract available.

PMID:
31466621
49.

Effects of Alirocumab on Cardiovascular Events After Coronary Bypass Surgery.

Goodman SG, Aylward PE, Szarek M, Chumburidze V, Bhatt DL, Bittner VA, Diaz R, Edelberg JM, Hanotin C, Harrington RA, Jukema JW, Kedev S, Letierce A, Moryusef A, Pordy R, Ramos López GA, Roe MT, Viigimaa M, White HD, Zeiher AM, Steg PG, Schwartz GG; ODYSSEY OUTCOMES Committees and Investigators.

J Am Coll Cardiol. 2019 Sep 3;74(9):1177-1186. doi: 10.1016/j.jacc.2019.07.015.

PMID:
31466614
50.

Cardiovascular risk reduction with icosapent ethyl.

Patel PN, Patel SM, Bhatt DL.

Curr Opin Cardiol. 2019 Nov;34(6):721-727. doi: 10.1097/HCO.0000000000000678.

PMID:
31464773

Supplemental Content

Support Center